ArticleJournal of nanobiotechnology2024

Inhalable hybrid nanovaccines with virus-biomimetic structure boost protective immune responses against SARS-CoV-2 variants.

Shuqi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.